Bioinnovation Leader Novozymes, Inc. Selects PROS Pricing Software to Support Profit Initiative

HOUSTON--(BUSINESS WIRE)--PROS (NYSE: PRO), the world leader in pricing and revenue management software, today announced that Novozymes, a leading bioinnovation company based in Denmark, selected PROS software as a key enabler to implement a profit improvement initiative as it expands its global footprint.

MORE ON THIS TOPIC